comparemela.com
Home
Live Updates
DCGI Withdraws Olaparib for Certain Cancer Treatments : comparemela.com
DCGI Withdraws Olaparib for Certain Cancer Treatments
India's DCGI orders the withdrawal of Olaparib for specific cancer treatments after reviewing adverse effects and survival data.
Related Keywords
India
,
Krishna Kripa
,
Astrazeneca
,
Astrazeneca Pharma India
,
Central Drugs Standard Control Organization
,
Some Cancer
,
Drug Controller General
,
Certain Cancers
,
Astrazeneca Pharma India Limited
,
Olaparib Tablets
,
comparemela.com © 2020. All Rights Reserved.